These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15506700)

  • 21. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Who will benefit from antiresorptive treatment (bisphosphonates)?
    Papapoulos SE
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidelines for the management of postmenopausal osteoporosis for GPs.
    O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF;
    Aust Fam Physician; 2004 Nov; 33(11):910-9. PubMed ID: 15584331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biphosphonates for the prevention of osteoporosis in postmenopausal women with a low bone mass].
    Pelayo M; Agra Y
    Med Clin (Barc); 2004 Mar; 122(8):304-10. PubMed ID: 15030743
    [No Abstract]   [Full Text] [Related]  

  • 27. Postmenopausal osteoporosis: act now to prevent fracture.
    Lidow IA; Rawlings NL
    Adv Nurse Pract; 2005 Sep; 13(9):41-4, 46, 59. PubMed ID: 16152816
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone-fracture risk in a wheelchair user.
    Wynne-Jones M; Pearce KE; Bhalla AK
    Practitioner; 2001 Sep; 245(1626):687, 690-2, 695-6. PubMed ID: 11584582
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
    Miller PD
    Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of vitamin D(3) over vitamin D(2) in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(2):89-91. PubMed ID: 18394507
    [No Abstract]   [Full Text] [Related]  

  • 32. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
    Hosoi T;
    Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical management of osteoporosis in the Philippines.
    Torralba TP
    Clin Calcium; 2004 Sep; 14(9):134-7. PubMed ID: 15577126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and treatment of postmenopausal osteoporosis.
    Lewiecki EM
    Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is treatment of early postmenopausal women with bisphosphonates justified?
    Epstein S
    Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Absolute risk for fracture and WHO guideline. Fall and fracture in elderly people : risk factors and strategies for prevention].
    Sugioka Y; Koike T;
    Clin Calcium; 2007 Jul; 17(7):1059-65. PubMed ID: 17607073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Active vitamin D metabolite and prevention of falls].
    Hayashi Y
    Clin Calcium; 2005 Apr; 15(4):655-60. PubMed ID: 15802780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture prevention in postmenopausal women.
    Mosekilde L; Vestergaard P; Langdahl B
    Am Fam Physician; 2008 May; 77(10):1447-8. PubMed ID: 18533379
    [No Abstract]   [Full Text] [Related]  

  • 40. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.